Lightning Round: Jim Cramer Weighs In On Juno Therapeutics, Halliburton And More By: Benzinga via Benzinga August 18, 2017 at 07:54 AM EDT On CNBC's "Mad Money Lightning Round", Jim Cramer said Juno Therapeutics Inc(NASDAQ: JUNO) is a high risk immunotherapy ... Read More >> Related Stocks: Bemis Company Chubb Limited Coupa Software Inc Halliburton Co Intuitive Surgical Landstar System Mazor Robotics Ads Merit Medical Sys Novartis Ag ADR Prudential Financial Siriusxm Holdings Inc TravelersCompanies Xpo Inc